Clinical Edge Journal Scan

Abdominal subcutaneous adipose tissue elicits sex-specific effects on coronary atherosclerosis in psoriasis


 

Key clinical point: For a certain body mass index (BMI), abdominal subcutaneous adipose tissue (ASAT) was negatively associated with coronary atherosclerosis burden in men with psoriasis.

Major finding: After adjusting for traditional risk factors and each patient's BMI, ASAT was negatively associated with noncalcified and lipid-rich necrotic core burden in men (β, 0.17; P = .03; β, 0.20; P = .03, respectively) but not in women (β, 0.06; P = .57; β, 0.09; P = .49, respectively) with psoriasis.

Study details: The data come from a cross-sectional study of 232 patients with psoriasis and without known cardiovascular disease, of which 92 were women.

Disclosures: The study was supported by National Heart, Lung, and Blood Institute Intramural Research Program (Bethesda, Maryland). Dr. Mehta declared being a current full-time U.S. government employee and receiving a research grant from various sources. Dr. Khera declared serving as a scientific advisor and receiving speaker fees from various sources.

Source: Teklu M et al. Am J Prev Cardiol. 2021 Aug 22. doi: 10.1016/j.ajpc.2021.100231 .

Recommended Reading

Biologic benefit in psoriasis might extend to arthritis prevention
MDedge Dermatology
Clinical Edge Journal Scan Commentary: Psoriasis September 2021
MDedge Dermatology
Ask about itch and joint pain in pediatric psoriasis patients, expert advises
MDedge Dermatology
Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains high
MDedge Dermatology
Depression vs anxiety: Prevalence and influence on health-related QoL in plaque psoriasis
MDedge Dermatology
Apremilast shows potential as a treatment option for nail psoriasis
MDedge Dermatology
Methotrexate or retinoids: Which one poses lower cardiovascular risks in psoriasis?
MDedge Dermatology
Calcipotriol-betamethasone more effective than calcipotriol alone in treating plaque psoriasis
MDedge Dermatology
Impact of psoriasis on clinical outcomes in patients with pulmonary embolism
MDedge Dermatology
Clobetasol propionate 0.025% is a safe treatment option for moderate-to-severe psoriasis
MDedge Dermatology